Joaquin Duato is Chairman and Chief Executive Officer of Johnson & Johnson. Under his leadership, J&J is now exclusively focused on tackling the toughest health challenges by developing innovative medicines and medtech solutions.

The company’s 130,000 employees work to transform health by building a world where complex diseases are prevented, treated, and cured—and where solutions are smarter, less invasive, and more personalized. Under Joaquin’s leadership, Johnson & Johnson is accelerating healthcare innovation using data science and the latest technology to create breakthroughs in care, from cell therapy to robotic-assisted surgery.

Before becoming CEO in January 2022 and Chairman in January 2023, Joaquin served as Vice Chairman of the Executive Committee, where he led the company’s pharmaceutical and consumer health businesses, as well as technology and global supply chain teams. Over three decades with the company, working across multiple geographies, functions, and business segments, Joaquin developed a deep understanding of the unique role J&J serves in solving patients’ health challenges.

A dual citizen of the U.S. and Spain, Joaquin earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona.

Member Company since 2013